484 related articles for article (PubMed ID: 17509079)
1. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
Melino S; Paci M
FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
[TBL] [Abstract][Full Text] [Related]
2. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
[TBL] [Abstract][Full Text] [Related]
3. The active essential CFNS3d protein complex.
Melino S; Fucito S; Campagna A; Wrubl F; Gamarnik A; Cicero DO; Paci M
FEBS J; 2006 Aug; 273(16):3650-62. PubMed ID: 16911516
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
5. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
Kurane I
Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
Murthy HM; Judge K; DeLucas L; Padmanabhan R
J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
[TBL] [Abstract][Full Text] [Related]
7. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
Lai H; Teramoto T; Padmanabhan R
Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
[TBL] [Abstract][Full Text] [Related]
8. Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain.
Arias CF; Preugschat F; Strauss JH
Virology; 1993 Apr; 193(2):888-99. PubMed ID: 8460492
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays.
Zuo Z; Liew OW; Chen G; Chong PC; Lee SH; Chen K; Jiang H; Puah CM; Zhu W
J Virol; 2009 Jan; 83(2):1060-70. PubMed ID: 18971276
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease.
Gao Y; Cui T; Lam Y
Bioorg Med Chem; 2010 Feb; 18(3):1331-6. PubMed ID: 20042339
[TBL] [Abstract][Full Text] [Related]
11. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
Green S; Rothman A
Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
13. Dengue vaccines approach the finish line.
Edelman R
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S56-60. PubMed ID: 17582571
[TBL] [Abstract][Full Text] [Related]
14. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.
Niyomrattanakit P; Yahorava S; Mutule I; Mutulis F; Petrovska R; Prusis P; Katzenmeier G; Wikberg JE
Biochem J; 2006 Jul; 397(1):203-11. PubMed ID: 16489931
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia.
Appanna R; Huat TL; See LL; Tan PL; Vadivelu J; Devi S
Clin Vaccine Immunol; 2007 Aug; 14(8):969-77. PubMed ID: 17567768
[TBL] [Abstract][Full Text] [Related]
16. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
[TBL] [Abstract][Full Text] [Related]
17. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
[TBL] [Abstract][Full Text] [Related]
18. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
19. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
20. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]